Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Vansen Pharma Inc. | Financial_Report.xls |
| EX-3.2 - ARTICLES OF MERGER - Vansen Pharma Inc. | oknv_ex32.htm |
| EX-3.1 - CERTIFICATE OF CHANGE - Vansen Pharma Inc. | oknv_ex31.htm |
| 10-Q - FORM 10-Q - Vansen Pharma Inc. | oknv_10q.htm |
| EX-31.1 - CERTIFICATION - Vansen Pharma Inc. | oknv_ex311.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Okana Ventures, Inc. (the "Company") on Form 10-Q for the period ended June 30, 2013 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Richard Azani, the President, Chief Executive Officer, Chief Financial Officer and Director (Principal Financial Officer) of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
|
(1)
|
the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
|
(2)
|
the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
|
|
Dated: August 19, 2013
|
By:
|
/s/ Richard Azani
|
|
|
Richard Azani
|
|||
|
Chief Executive Officer, Chief Financial Officer, Secretary, Treasurer and Director (Principal Executive and Principal Financial and Accounting Officer)
|